Appraisal of available literature published from January 2019 to April 2020 yielded a total of 98 studies, 14 of which pertained to aminoglycosides, 26 to fluoroquinolones, 23 to glycopeptides, 3 to clindamycin, 13 to macrolides, 7 to oxazolidinones, 4 to polymyxins, 5 to trimethoprim/sulfamethoxazole, 2 to daptomycin, 1 to nitrofurantoin, 1 to fosfomycin, and 1 to lefamulin. Our search yielded no pertinent literature for tedizolid and for trimethoprim alone.
|Title of host publication||A Worldwide Yearly Survey of New Data in Adverse Drug Reactions|
|Editors||Sidhartha D. Ray|
|Number of pages||14|
|State||Published - Jan 2020|
|Name||Side Effects of Drugs Annual|
- Urinary antibiotics